Barely Significant
← all excerpts

Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review.

Diabetes Ther · 2024 · PMC11263312 · PMID 38935188

Europe PMCDOI
1
hedged sentence
0.0520
closest p · 1.0× alpha
0.0520
boldest claim

The sentences

nearly significantp = 0.052so close (0.05 < p ≤ 0.1)
In the United Kingdom Prospective Diabetes Study (UKPDS) conducted in newly diagnosed patients with T2D, intensive treatment (insulin and SU-based therapies) was associated with significant reduction in microvascular complications by 25% ( p = 0.0099) and a nearly significant decrease in macrovascular complications by 16% ( p = 0.052) compared with conventional treatment at 1 year [ 27 ].

also in 3,349 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.